NewsBenzingaMonte Rosa recibirá un pago por hito de 37,5 millones de dólares de Novartis tras el inicio del segundo ensayo de fase 2 de MRT-6160 en artritis psoriásica Monte Rosa recibirá un pago por hito de 37,5 millones de dólares de Novartis tras el inicio del segundo ensayo de fase 2 de MRT-6160 en artritis psoriásica Benzinga 2026.10.28 11:08 (GMT+0) Open on Benzinga Other news Hearing Nvidia Chair Says Jensen Huang Not Coming Back Here’s How Much You Would Have Made Owning KLA Stock In The Last 20 Years Freedom Broker Maintains Buy on Euroseas, Raises Price Target to $96 Sam Altman says his life is so weird that he’s unphased by Andrew Garfield portraying him in upcoming movie Freedom Broker Maintains Buy on JD.com, Lowers Price Target to $40 I Used This Options Strategy to Profit from the Post-IPO Plunge in SpaceX. Now I’ll Use It Again on ANT Stock After Anthropic Starts Trading.
Sam Altman says his life is so weird that he’s unphased by Andrew Garfield portraying him in upcoming movie
I Used This Options Strategy to Profit from the Post-IPO Plunge in SpaceX. Now I’ll Use It Again on ANT Stock After Anthropic Starts Trading.